Tim Scott actually said...

To not take the original intent on the first biosimilar immediately as it's coming out seems to me to be a costly delay.

I think to some extent Senator Murphy started having the conversation about the appropriate education necessary for the clinicians.

My last comment would be that I know that you've been dedicated to this cause for it sounds like nearly 20 years.

Frankly, if we're looking for a way, as Senator Murphy has inferred to controlling and/or reducing the cost, whether it's 30 percent or 20 p...